# A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults

> **NCT00116818** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 90 (actual)

## Conditions studied

- Rhinitis, Allergic, Perennial

## Interventions

- **DRUG:** GW685698X aqueous nasal spray

## Key facts

- **NCT ID:** NCT00116818
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116818, "A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00116818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*